89bio, Inc. logo ETNB - 89bio, Inc.

Inactive Ticker ETNB is not actively trading. Quotes and analytics may be stale.
Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY 0
BUY 9
HOLD 6
SELL 0
STRONG
SELL 0
| PRICE TARGET: $17.17 DETAILS
HIGH: $25.00
LOW: $12.00
MEDIAN: $14.50
CONSENSUS: $17.17
UPSIDE: 15.70%
Annual Quarterly
Metric 2024 2023 2022 2021 2020 2019 2018
Revenue
Revenue 0 0 0 0 0 0 0
Cost of Revenue 0.0 0.3 0.2 0.1 0.1 0.0 0.0
Gross Profit (0.0) (0.3) (0.2) (0.1) (0.1) (0.0) (0.0)
Operating Expenses
R&D Expenses 345.0 122.2 80.8 70.3 36.2 21.3 13.7
SG&A Expenses 39.6 29.0 21.5 19.4 13.2 5.3 1.5
Other Expenses 0 0 0 0 0 0 0
Operating Expenses 384.7 151.2 102.2 89.7 49.4 26.6 15.2
Operating Income
Operating Income (384.7) (151.2) 102.2 (89.7) (49.4) (26.6) (15.2)
Interest Expense 3.8 3.6 1.9 0.7 0 0 0
Interest Income 0 0 2.2 0.1 0 0 0
Profitability
EBITDA (384.7) (134.5) (99.8) (90.2) (49.5) (57.2) (16.1)
EBIT (371.7) (134.7) (100.1) (90.3) (49.6) (57.2) (16.1)
Income Before Tax (366.4) (138.3) (102.0) (90.3) (49.6) (57.2) (16.1)
Income Tax Expense 0.7 3.9 0.0 (0.1) (0.1) 0.2 0.0
Net Income (367.1) (142.2) (102.0) (90.1) (49.5) (57.4) (16.2)
Per Share Data
EPS (Basic) -3.51 -2.00 -2.93 -4.48 -3.08 -5.40 -3.53
EPS (Diluted) -3.51 -2.00 -2.93 -4.48 -3.08 -5.40 -3.53
Shares Outstanding 104.7 71.2 34.8 20.1 16.1 10.6 4.6
Metric 2024 2023 2022 2021 2020 2019 2018
Current Assets
Cash & Cash Equivalents 126.1 316.2 55.3 52.4 98.2 93.4 11.2
Short-Term Investments 313.9 262.7 132.9 98.3 106.4 0 0
Net Receivables 0 0 0 0 0 0 0
Inventory 0 0 0 0 0 0 0
Other Current Assets 0 0 0 0 0 0 0.0
Total Current Assets 476.4 593.5 196.1 162.0 210.2 95.3 11.3
Non-Current Assets
Property, Plant & Equipment 1.6 2.3 0.5 0.1 0.2 0.2 0.0
Goodwill 0 0 0 0 0 0 0
Intangible Assets 0 0 0 0 0 0 0
Long-Term Investments 0 0 0 0 0 0 0
Other Non-Current Assets 0.6 0.4 0.3 0.3 0.7 0.1 0
Total Non-Current Assets 2.2 2.7 0.7 0.4 0.9 0.2 0.1
Total Assets 478.7 596.3 196.8 162.4 211.1 95.6 11.4
Current Liabilities
Account Payables 15.4 8.6 12.5 6.8 2.1 1.0 1.5
Short-Term Debt 0 0 0 2.5 0 0 0
Deferred Revenue 0 0 0 0 0 0 0
Other Current Liabilities 6.9 6.2 4.2 3.2 2.6 1.4 2.0
Total Current Liabilities 36.1 29.6 24.6 19.5 8.1 5.6 4.4
Non-Current Liabilities
Long-Term Debt 35.7 24.8 20.2 16.9 0 0 0
Deferred Tax Liabilities 0 0 0 0 0 0 0
Other Non-Current Liabilities 4.9 3.7 0 0.0 0 0 0
Total Non-Current Liabilities 41.8 30.4 20.4 16.9 0 0 23.1
Total Liabilities 77.9 60.0 45.0 36.5 8.1 5.6 27.4
Stockholders' Equity
Common Stock 0.1 0.1 0.1 0.0 0.0 0.0 0.0
Retained Earnings (824.5) (457.4) (315.2) (213.2) (123.1) (73.6) (16.2)
Accumulated Other Comprehensive Income 0.6 0.2 (0.3) (0.1) (0.0) (95.6) (0.0)
Total Stockholders' Equity 400.8 536.3 151.8 126.0 203.0 89.9 (16.1)
Total Liabilities & Equity 478.7 596.3 196.8 162.4 211.1 95.6 11.4
Debt Metrics
Total Debt 37.5 27.1 20.5 19.4 0 0 24.7
Net Debt (88.5) (289.1) (34.7) (33.0) (98.2) (93.4) 13.5
Metric 2024 2023 2022 2021 2020 2019 2018
Operating Activities
Net Income (367.1) (142.2) (102.0) (90.1) (49.5) (57.4) (16.2)
Depreciation & Amortization (9.1) 0.1 0.1 0.1 0.1 0.0 0.0
Stock-Based Compensation 20.6 16.1 10.4 8.7 3.8 0.4 0.1
Change in Working Capital (14.5) 0.7 10.6 3.3 (1.0) 0.9 2.6
Other Non-Cash Items 2.3 (3.9) (0.0) 1.5 0.5 30.6 1.0
Operating Cash Flow (367.8) (129.2) (81.1) (76.8) (46.2) (25.5) (12.5)
Investing Activities
Capital Expenditure (0.0) (0.0) (0.0) (0.1) (0.1) (0.1) (0.0)
Acquisitions 0 0 0.0 (0.0) 0.1 0 0
Purchases of Investments (376.1) (341.1) (152.7) (141.2) (118.9) 0 0
Sales/Maturities of Investments 335.2 218.1 118.8 148.4 12.2 0 0
Other Investing Activities 0 0 (0.0) 0.0 (0.1) 0 0
Investing Cash Flow (40.9) (123.0) (33.9) 7.2 (106.8) (0.1) (0.0)
Financing Activities
Net Debt Issuance 9.3 3.0 0 20.0 0 0 0.1
Stock Repurchased 0 0.3 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0
Other Financing Activities 51.7 13.6 0.8 0.1 0.2 0 0
Financing Cash Flow 218.6 513.1 117.8 23.9 157.9 107.7 23.8
Cash Position
Net Change in Cash (190.1) 260.9 2.8 (45.8) 4.8 82.1 11.3
Cash at Beginning 316.2 55.3 52.5 98.2 93.4 11.3 0
Cash at End 126.1 316.2 55.3 52.5 98.2 93.4 11.3
Free Cash Flow (367.8) (129.2) (81.1) (76.8) (46.4) (25.6) (12.5)
Key Metrics 2024 2023 2022 2021 2020 2019 2018
Income Statement
Revenue 0 0 0 0 0 0 0
Gross Profit (0.0) (0.3) (0.2) (0.1) (0.1) (0.0) (0.0)
Operating Income (384.7) (151.2) 102.2 (89.7) (49.4) (26.6) (15.2)
Net Income (367.1) (142.2) (102.0) (90.1) (49.5) (57.4) (16.2)
EPS (Diluted) -3.51 -2.00 -2.93 -4.48 -3.08 -5.40 -3.53
Balance Sheet
Cash & Equivalents 126.1 316.2 55.3 52.4 98.2 93.4 11.2
Total Assets 478.7 596.3 196.8 162.4 211.1 95.6 11.4
Total Debt 37.5 27.1 20.5 19.4 0 0 24.7
Stockholders' Equity 400.8 536.3 151.8 126.0 203.0 89.9 (16.1)
Cash Flow
Operating Cash Flow (367.8) (129.2) (81.1) (76.8) (46.2) (25.5) (12.5)
Capital Expenditure (0.0) (0.0) (0.0) (0.1) (0.1) (0.1) (0.0)
Free Cash Flow (367.8) (129.2) (81.1) (76.8) (46.4) (25.6) (12.5)